BRAF–KIAA fusions, which lead to constitutive activation of the BRAF protein, are common in cerebellar and optic pathway pilocytic tumors, whereas BRAF mutations are more common in gangliogliomas, pleomorphic xanthoastrocytomas, and cerebral pilocytic astrocytomas [25]. Here, BRAF is linked to ganglioglioma.